Selective C-reactive protein apheresis for Covid-19 patients suffering from organ damage.

Kayser, Stefan; Kunze, Rudolf; Sheriff, Ahmed

Kayser, Stefan; Kunze, Rudolf; Sheriff, Ahmed.

Kayser S; Pentracor GmbH, Hennigsdorf, Germany.
Kunze R; Science Office, Hessenhagen, Germany.
Sheriff A; Pentracor GmbH, Hennigsdorf, Germany.

Ther Apher Dial ; 25(2): 251-252, 2021 04.

Article in English | MEDLINE | ID: covidwho-535339

Subject(s)

Blood Component Removal/methods; C-Reactive Protein/adverse effects; COVID-19/therapy; Heart Diseases/prevention & control; Pulmonary Fibrosis/prevention & control; COVID-19/blood; COVID-19/complications; Heart Diseases/blood; Heart Diseases/complications; Humans; Pulmonary Fibrosis/blood; Pulmonary Fibrosis/complications; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Fibrosis / Blood Component Removal / C-Reactive Protein / COVID-19 / Heart Diseases Topics: Long Covid Limits: Humans Language: English Journal: Ther Apher Dial Journal subject: Hematology Year: 2021 Document Type: Article Affiliation country: 1744-9987.13532

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google